Physician profile
Amy Hammers
NPI 1578852224
$550.17
in general payments reported to CMS, 2019-2025
19 companies · $42.19 in 2025
The $42.19 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $141 · 2020: $38.25 · 2021: $77.10 · 2022: $92.66 · 2023: $70.06 · 2024: $88.45 · 2025: $42.19.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $201.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $200.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $76.67 | 2019-2024 | |
| Exeltis, USA INC. | $75.93 | 2021-2023 | Slynd |
| Sage Therapeutics, LLC | $51.85 | 2024 | |
| Therapeuticsmd, INC. | $48.08 | 2019-2021 | |
| Roche Diagnostics Corporation | $44.27 | 2019 | |
| Hologic Sales and Service, LLC | $42.34 | 2021-2025 | Acessa Provu System, Novasure |
| Daiichi Sankyo INC. | $23.42 | 2022 | |
| Mayne Pharma Commercial LLC | $21.90 | 2023 | |
| Pfizer INC. | $20.68 | 2025 | |
| Convatec INC. | $20.00 | 2019 | |
| Astellas Pharma US INC | $17.22 | 2024 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $15.37 | 2022 | |
| Vertical Pharmaceuticals, LLC | $14.64 | 2019 | |
| Lupin INC. | $13.89 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $13.38 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $12.80 | 2023 | Myfembree |
| Myovant Sciences INC. | $12.73 | 2022 | |
| Coopersurgical, INC. | $12.54 | 2020 | |
| Olympus America INC. | $12.46 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Hammers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.